Nature of "Tau" immunoreactivity in normal myonuclei and inclusion body myositis.
Nature of "Tau" immunoreactivity in normal myonuclei and inclusion body myositis.
复制标题
正常肌核和包涵体肌炎中“Tau”免疫反应性的性质。
DOI:
10.1002/mus.21471
复制
发表时间:
2009
期刊:
影响因子:
3.4
通讯作者:
Greenberg,StevenA
中科院分区:
文献类型:
--
作者:
Salajegheh,Mohammad;Pinkus,JackL;Nazareno,Remedios;Amato,AnthonyA;Parker,KennethC;Greenberg,StevenA
Sarcoplasmic accumulation of phosphorylated‐tau has been widely stated to occur in and contribute to the pathogenesis of muscle disease in inclusion body myositis. Twenty inflammatory myopathy and 10 normal muscle samples along with a range of other tissues were stained with anti‐“tau” antibodies (tau‐5, pS422, and SMI‐31). Myonuclear and sarcoplasmic fractions were prepared using differential solubilization and laser‐capture microdissection, and immunoblots were performed using pS422 and SMI‐31 antibodies. All three antibodies demonstrated anti‐tau immunoreactivity in myonuclei from normal and diseased muscle, but not in nuclei from other tissues. Western blots showed pS422 and SMI‐31 immunoreactivity against nuclear proteins outside the region expected for phosphorylated‐tau. Antibodies previously reported to indicate abnormal accumulation of phosphorylated‐tau in IBM myofibers react to normal myonuclei and recognize proteins other than tau. Normal myonuclei contain neurofilament H or other unidentified 200 kDa proteins with similar phosphorylated motifs accounting for SMI‐31 immunoreactivity. Muscle Nerve, 2009